• Nitra

  Participated · Series B · Mar 2026

  Nitra embeds AI agents into core business functions—payments, procurement, inventory management, scheduling, and insurance verification—giving medical practices a single system to run their back office. Its financial suite includes a Visa-powered expense card, bill pay, patient payment processing, and AI-driven accounting, while its commerce marketplace connects users to thousands of biopharma and medical-supply products through partners like McKesson and Medline. Recently the company added a voice-AI patient management module that handles appointment scheduling and insurance eligibility checks. In 2025 the platform’s annualized revenue jumped from $4 million to more than $33 million on 740 percent growth, and it surpassed $1 billion in annualized processing volume across thousands of doctors in over 700 clinics. December 2025 saw a single-day record of roughly $9 million in purchases. Management expects to serve 3,000+ clinics, top $150 million in annualized revenue, and exceed $4 billion in processing volume during 2026. Founded in 2024 by CEO Tim Hwang and President Jonathan Chen, Nitra plans to expand headcount from about 50 to over 200 and roll out new AI modules for revenue-cycle management, patient marketing, payroll, and staffing.

• Petal Surgical

  Led · Series A · Oct 2025

  Petal Surgical is developing an incisionless surgery platform that uses Millisecond Pulse Histotripsy — a form of acoustic liquefaction — integrated with robotics, imaging and AI-driven controls to precisely treat tissue. The platform creates vapor-filled cavities one at a time to enable connected treatment regions and break down tougher tissues without cutting. The company says its approach aims to eliminate cuts, pain, trauma and other typical surgical risks and to leverage the body's natural healing. Petal plans to use recent financing to accelerate R&D, expand clinical readiness activities and advance toward first-in-human studies. The company was founded by image-guided surgery engineer Prash Chopra alongside neurosurgeon Dr. Bowen Jiang, spine-surgery pioneer Dr. Nicholas Theodore, and Rony Abovitz, a founder of Mako Surgical. Petal has drawn board and investor support from figures such as Dr. Fred Moll and Lip-Bu Tan.

• Arvo

  Participated · Series A · Sep 2025

  Founded in 2022, Arvo offers an AI-powered platform that serves healthcare providers and health-insurance operators, flagging fraudulent, erroneous, or wasteful items in claims before payments are processed. Its technology integrates large data sets and applies machine-learning models to bring greater security, transparency, and efficiency to healthcare transactions. The company positions itself as an anti-fraud layer within the Brazilian healthcare payment system, aiming to lower costs and improve cash-flow accuracy for its clients. Fresh capital from its latest fundraise brings total disclosed funding to R$106 million. Management plans to deploy this Series A money to expand operations across Brazil, enhance AI-driven transaction processing, launch new products, and scale its data science and engineering teams. Headquartered in São Paulo, Arvo is building out both technical and commercial staff to capture growing demand for automated claims analysis in the region.

• Persona AI

  Participated · Seed · May 2025

  Persona AI develops bipedal humanoid robots designed to perform welding and other skilled trades in heavy manufacturing, with an initial focus on shipbuilding. The company has iterated three hardware generations in 24 months, performed its first untethered weld in a Houston shop, and demonstrated outdoor walking in protective materials. Persona AI has units already at HD Hyundai and plans prototype delivery by the end of 2026 with commercialization in 2027. It plans to offer robots via a robotics-as-a-service (RaaS) model to reduce customer capital expenditure and enable large-scale fleet deployments. The founding team includes veterans from NASA and prior humanoid efforts, and the company targets markets with acute labor shortages and repetitive, high-value welding work.

• Carecode

  Participated · Seed · Dec 2024

  Carecode builds AI agents that handle tasks before and after medical appointments—functions typically run by call centers—aiming to reduce costs and improve outcomes. The startup supports WhatsApp text and audio today and plans voice calls on the roadmap. It positions itself as a vertical, healthcare-focused solution tailored to Brazil’s market and user preferences. Early pilots with an unnamed partner reportedly show agents can perform most call-center work, proactively fill cancelled slots, and leave complex cases to human staff. Carecode emerged from stealth and emphasizes localization (e.g., WhatsApp audio) as a competitive differentiator versus horizontal U.S. competitors. Founders include CEO Thomaz Srougi, who previously founded Dr. Consulta, and co-founder Pedro Magalhães, a former CTO at several Brazilian startups. The team sees potential to later expand into adjacent areas like insurance, payments, and financing tied to healthcare.

No current team members are available.